News & UpdatesAmjevita approved by FDA for multiple inflammatory diseases.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Abbvie product Humira (adalimumab) for multiple inflammatory diseases. Enbrel and Humira belong to a class of drugs that treating inflammation by blocking a protein known as tumor necrosis factor. Manufactured by Amgen. Amjevita is approved for the treatment of : moderately…
Sep 23, 2016
